The HPV vaccine mandate controversy.
暂无分享,去创建一个
[1] Christophe Fraser,et al. Modeling the long-term antibody response of a human papillomavirus (HPV) virus-like particle (VLP) type 16 prophylactic vaccine. , 2007, Vaccine.
[2] J. Bost,et al. Impact of addition of philosophical exemptions on childhood immunization rates. , 2007, American journal of preventive medicine.
[3] Erik J. Dasbach,et al. Model for Assessing Human Papillomavirus Vaccination Strategies , 2007, Emerging infectious diseases.
[4] J. Colgrove. The ethics and politics of compulsory HPV vaccination. , 2006, The New England journal of medicine.
[5] H. Cubie,et al. Public awareness of human papillomavirus , 2006, Journal of medical screening.
[6] G. Krogh,et al. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up , 2006, British Journal of Cancer.
[7] X. Castellsagué,et al. Comparison of the Immunogenicity and Reactogenicity of a Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine in Male and Female Adolescents and Young Adult Women , 2006, Pediatrics.
[8] Lawrence H Moulton,et al. Nonmedical exemptions to school immunization requirements: secular trends and association of state policies with pertussis incidence. , 2006, JAMA.
[9] S. Kalichman,et al. HIV Treatment Beliefs and Sexual Transmission Risk Behaviors among HIV Positive Men and Women , 2006, Journal of Behavioral Medicine.
[10] G. Zimet,et al. Chapter 24: Psychosocial aspects of vaccine acceptability. , 2006, Vaccine.
[11] C. Wheeler,et al. Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18. , 2006, Vaccine.
[12] B. Lo. HPV vaccine and adolescents' sexual activity , 2006, BMJ : British Medical Journal.
[13] C. Wheeler,et al. Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial , 2006, The Lancet.
[14] S. Teret,et al. Compulsory vaccination and conscientious or philosophical exemptions: past, present, and future , 2006, The Lancet.
[15] C. Kemper,et al. Use of and Adherence to Antiretroviral Therapy Is Associated With Decreased Sexual Risk Behavior in HIV Clinic Patients , 2005, Journal of acquired immune deficiency syndromes.
[16] Cosette M Wheeler,et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. , 2005, The Lancet. Oncology.
[17] Matthew M Davis,et al. Associations of daycare and school entry vaccination requirements with varicella immunization rates. , 2005, Vaccine.
[18] G. Martinez,et al. Teenagers in the United States: sexual activity, contraceptive use, and childbearing, 2002. , 2004, Vital and health statistics. Series 23, Data from the National Survey of Family Growth.
[19] Daron G Ferris,et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial , 2004, The Lancet.
[20] G. Sanders,et al. Evaluating Human Papillomavirus Vaccination Programs , 2004, Emerging infectious diseases.
[21] M. Schiff,et al. Dose-ranging studies of the safety and immunogenicity of human papillomavirus Type 11 and Type 16 virus-like particle candidate vaccines in young healthy women. , 2004, Vaccine.
[22] G. Marks,et al. Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review. , 2004, JAMA.
[23] Milton C Weinstein,et al. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. , 2004, Journal of the National Cancer Institute.
[24] Shalini L Kulasingam,et al. Potential health and economic impact of adding a human papillomavirus vaccine to screening programs. , 2003, JAMA.
[25] H. Margolis,et al. Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs. , 2002, The Journal of infectious diseases.
[26] D. Kirby. The impact of schools and school programs upon adolescent sexual behavior , 2002, Journal of sex research.
[27] D. Vlahov,et al. Sexual and drug risk-related behaviours after initiating highly active antiretroviral therapy among injection drug users , 2001, AIDS.
[28] R. Hamman,et al. Individual and community risks of measles and pertussis associated with personal exemptions to immunization. , 2000, JAMA.
[29] A. Hinman,et al. The immunization system in the United States - the role of school immunization laws. , 1999, Vaccine.
[30] A. Jemal,et al. Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.
[31] A. Hinman,et al. Childhood immunization: laws that work. , 2002, The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics.
[32] L. Rodewald,et al. Processes for obtaining nonmedical exemptions to state immunization laws. , 2001, American journal of public health.
[33] H. Margolis,et al. The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. , 1990, JAMA.